Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study

Archives of Dermatology
Bruce E StroberJerry Shapiro

Abstract

To assess the efficacy of alefacept for the treatment of severe alopecia areata (AA). Multicenter, double-blind, randomized, placebo-controlled clinical trial. Academic departments of dermatology in the United States. Forty-five individuals with chronic and severe AA affecting 50% to 95% of the scalp hair and resistant to previous therapies. Intervention Alefacept, a US Food and Drug Administration-approved T-cell biologic inhibitor for the treatment of moderate to severe plaque psoriasis. Main Outcome Measure Improved Severity of Alopecia Tool (SALT) score over 24 weeks. Participants receiving alefacept for 12 consecutive weeks demonstrated no statistically significant improvement in AA when compared with a well-matched placebo-receiving group (P = .70). Conclusion Alefacept is ineffective for the treatment of severe AA.

Citations

Oct 2, 2015·Seminars in Immunopathology·C Schlapbach, A A Navarini
May 11, 2016·Expert Opinion on Biological Therapy·Yael Renert-Yuval, Emma Guttman-Yassky
Jun 25, 2017·Advances in Therapy·Yael Renert-Yuval, Emma Guttman-Yassky
Nov 28, 2013·Pharmaceuticals·David Chandler, Anthony Bewley
Jun 22, 2017·The Journal of Dermatology·Solam Lee, Won-Soo Lee
Sep 8, 2018·The Australasian Journal of Dermatology·Vivien Wai Yun LaiRodney Sinclair
May 24, 2018·The British Journal of Dermatology·F RajabiN Rezaei
May 1, 2010·Seminars in Cutaneous Medicine and Surgery·Michael P Heffernan, Craig L Leonardi
Jul 9, 2014·American Journal of Clinical Dermatology·Maria Hordinsky, Aline Donati
Apr 25, 2012·The British Journal of Dermatology·A G MessengerM Sladden
Mar 17, 2017·Nature Reviews. Disease Primers·C Herbert PrattJohn P Sundberg
Oct 4, 2019·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Alfredo RossiMaria C Fortuna
Jul 13, 2012·Journal of Cutaneous Medicine and Surgery·Chantal Bolduc, Robert Bissonnette
May 28, 2021·Journal of the American Academy of Dermatology·Celina DubinEmma Guttman-Yassky
Aug 6, 2021·ImmunoTargets and Therapy·Poonkiat SuchonwanitCherrin Pomsoong
Aug 18, 2021·Clinical Reviews in Allergy & Immunology·Cheng ZhouJianzhong Zhang
Sep 3, 2021·Journal of the American Academy of Dermatology·Brett A KingMaryanne M Senna
Jan 19, 2022·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Dimitra Aikaterini LintzeriUlrike Blume-Peytavi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Dermatology
Natalie Garcia BartelsUlrike Blume-Peytavi
Dermatology : International Journal for Clinical and Investigative Dermatology
A C KatoulisN G Stavrianeas
Dermatology : International Journal for Clinical and Investigative Dermatology
Nedzmidin PelivaniNikhil Yawalkar
Dermatology : International Journal for Clinical and Investigative Dermatology
Y ChavesJ F Nicolas
© 2022 Meta ULC. All rights reserved